Sorafenib and everolimus in patients with advanced solid tumors and 
KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET 
assessment

Nogova, Lucia; Mattonet, Christian; Scheffler, Matthias; Taubert, Max; Gardizi, Masyar; Sos, Martin L.; Michels, Sebastian; Fischer, Rieke N.; Limburg, Meike; Abdulla, Diana S.Y.; Persigehl, Thorsten; Kobe, Carsten; Merkelbach-Bruse, Sabine; Franklin, Jeremy; Backes, Heiko; Schnell, Roland; Behringer, Dirk; Kaminsky, Britta; Eichstaedt, Martina; Stelzer, Christoph; Kinzig, Martina; Sörgel, Fritz; Tian, Yingying; Junge, Lisa; Suleiman, Ahmed A.; Frechen, Sebastian; Rokitta, Dennis; Ouyang, Dongsheng; Fuhr, Uwe; Buettner, Reinhard; Wolf, Jürgen

doi:10.1002/cam4.3131

Local TagsRelease HistoryDetailsSummary

Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment

Nogova, L., Mattonet, C., Scheffler, M., Taubert, M., Gardizi, M., Sos, M. L., et al. (2020). Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment. Cancer Medicine, 9(14), 4991-5007. doi:10.1002/cam4.3131.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-0006-77D1-8 Version Permalink: https://hdl.handle.net/21.11116/0000-000D-0802-8

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Nogova, Lucia, Author
Mattonet, Christian, Author
Scheffler, Matthias, Author
Taubert, Max, Author
Gardizi, Masyar, Author
Sos, Martin L.¹, Author
Michels, Sebastian, Author
Fischer, Rieke N., Author
Limburg, Meike, Author
Abdulla, Diana S.Y., Author
Persigehl, Thorsten, Author
Kobe, Carsten, Author
Merkelbach-Bruse, Sabine, Author
Franklin, Jeremy, Author
Backes, Heiko², Author
Schnell, Roland, Author
Behringer, Dirk, Author
Kaminsky, Britta, Author
Eichstaedt, Martina, Author
Stelzer, Christoph, Author
Kinzig, Martina, AuthorSörgel, Fritz, AuthorTian, Yingying, AuthorJunge, Lisa, AuthorSuleiman, Ahmed A., AuthorFrechen, Sebastian, AuthorRokitta, Dennis, AuthorOuyang, Dongsheng, AuthorFuhr, Uwe, AuthorBuettner, Reinhard, AuthorWolf, Jürgen, Author more..

Affiliations:
1Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656
2Backes, Wiedermann – Multimodal Imaging, Scientific Services and Development, Max Planck Institute for Metabolism Research, Max Planck Society, ou_3485607

Content

show

Details

show

hide

Language(s): eng - English

Dates: Accepted: 2020Date issued: 2020

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: DOI: 10.1002/cam4.3131

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Cancer Medicine

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 9 (14) Sequence Number: - Start / End Page: 4991 - 5007 Identifier: ISSN: 20457634